Related Experiment Video
Updated: Jun 25, 2026
12:08
Improving IV Insulin Administration in a Community Hospital
Published on: June 11, 2012
Automated Insulin Delivery: Great Strides in the Past, Great Needs for the Future
Rachel Seese1, Charlotte Katie Boughton1,2, Roman Hovorka1
1Institute of Metabolic Science-Metabolic Research Laboratories, University of Cambridge, Cambridge, U.K.
Diabetes Care
|June 24, 2026
Summary
Automated insulin delivery (AID) systems are revolutionizing type 1 diabetes management. This review covers current hybrid systems, future fully automated options, and their application in diverse patient groups.
Area of Science:
- Endocrinology and Metabolism
- Biomedical Engineering
- Medical Technology
Background:
- Diabetes technology is rapidly advancing, significantly impacting diabetes management.
- Hybrid automated insulin delivery (AID) systems represent a major translational success from research to clinical practice.
Purpose of the Study:
- To review the development, commercialization, and selection factors for current hybrid AID systems.
- To explore advancements toward next-generation fully automated insulin delivery systems.
- To examine the expanding applications of AID in various diabetes populations and settings.
Main Methods:
- Literature review focusing on automated insulin delivery systems.
- Analysis of factors influencing AID system selection by users and healthcare professionals.
- Discussion of technological approaches for future fully automated systems.
- Review of emerging evidence for AID in specific patient cohorts.
Main Results:
- Hybrid AID systems have seen successful translation from bench to bedside.
- A growing choice of AID systems presents challenges in comparison and selection.
- Future fully automated systems may incorporate ultrarapid insulins, adjunctive therapies, wearables, or dual-hormone approaches.
- Emerging evidence supports AID use in vulnerable type 1 diabetes populations, type 2 diabetes, cystic fibrosis-related diabetes, and inpatient settings.
Conclusions:
- Automated insulin delivery systems are transforming diabetes care, with ongoing innovation towards full automation.
- Addressing the diabetes technology ecosystem is crucial for equitable access and effective implementation.
- AID shows promise for broader application across diverse clinical scenarios and patient groups.
Related Concept Videos
01:27Insulin Formulations: Types and Delivery
Insulin preparations are categorized by their duration of action into short-acting and long-acting types. Two strategies are used to modify insulin's absorption and pharmacokinetic profile: slowing the absorption post-subcutaneous injection, or altering human insulin's amino acid sequence or protein structure. These changes retain the insulin's ability to bind to the insulin receptor, but alter its behavior in solution or after injection.
Short-acting insulins are divided into rapid-acting...
Short-acting insulins are divided into rapid-acting...
01:28Parenteral Drug Delivery Systems: Injectables, Implants, and Infusion Devices
Parenteral drug delivery systems play a crucial role in modern therapeutics by enabling the direct administration of drugs into the systemic circulation, bypassing the gastrointestinal tract. These systems are particularly valuable for poorly absorbed oral medications that are unstable in the digestive environment or require rapid onset or sustained therapeutic levels. Delivery is achieved through intravenous, intramuscular, or subcutaneous routes, each selected based on the drug's properties...
01:16Insulin: Dosing Regimen and Adverse Effects
Insulin-replacement therapy usually includes both long-acting insulin (basal) and short-acting insulin (to cater to postprandial needs). In a diverse group of type 1 diabetes patients, the average daily insulin dose is typically 0.5-0.7 units/kg body weight. However, obese patients and pubertal adolescents may need more due to insulin resistance.
The basal dose constitutes about 40%-50% of the total daily dose, with the rest as premeal insulin. The mealtime insulin dose should mirror...
The basal dose constitutes about 40%-50% of the total daily dose, with the rest as premeal insulin. The mealtime insulin dose should mirror...
01:25Insulin: Biosynthesis, Chemistry, and Preparation
The endoplasmic reticulum (ER) of pancreatic β-cells synthesizes preproinsulin, which consists of a signal peptide, A and B chains, and a C-peptide. Preproinsulin is then cleaved and folded into proinsulin, which translocates to the Golgi apparatus for sorting and packaging into secretory granules. In these granules, enzymatic clipping generates insulin and C-peptide.
Damage or functional impairment of β-cells inhibits insulin production, leading to diabetes. Diabetes treatment primarily uses...
Damage or functional impairment of β-cells inhibits insulin production, leading to diabetes. Diabetes treatment primarily uses...
01:29Issues And Trends In Healthcare Delivery System
The issues and trends in healthcare delivery are constantly changing. The COVID-19 pandemic is one recent issue that wreaked havoc on healthcare systems, causing a shortage of healthcare workers, high demand for medicines and supplies, and increased medical expenditure due to a lack of insurance. Other issues include rising healthcare costs and care fragmentation.
Cost Containment
Payment for healthcare services has historically promoted adoption of costly and often unnecessary or inefficient...
Cost Containment
Payment for healthcare services has historically promoted adoption of costly and often unnecessary or inefficient...
01:30Production of Pharmaceuticals
Industrial insulin production uses genetically engineered E. coli expressing a proinsulin gene controlled by a tryptophan promoter and containing a methionine linker for later cleavage. The cells also carry ampicillin resistance for selective growth. Seed cultures are stored at −80 °C and production begins by thawing a small amount to inoculate starter cultures, which are progressively scaled to a 50,000-L bioreactor. In the bioreactor, E. coli grow in nutrient-rich media under sterile, tightly...